Accendra Health, Inc. (ACH)

NYQ – Real Time Price. Currency in USD

1.21

-0.06 (-4.37%)

At close: Aug 12, 2026, 3:59 PM EDT

1.21

-0.00 (-0.12%)

After-hours: Aug 12, 2026, 4:26 PM EDT

10.08.2026

Accendra Health, Inc. (ACH) Q2 2026 Earnings Call Transcript

10.08.2026

Accendra Health Announces Adoption of Tax Asset Preservation Plan To Protect Long Term Shareholder Value

RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the Company) announced today that its Board of Directors adopted a Section 382 Rights Agreement (the “Tax Asset Preservation Plan”) designed to protect long-term shareholder value by facilitating the Company's ability to preserve its net operating loss carryforwards (“NOLs”) and certain other tax attributes. A company generally experiences an ownership change if the percentage of the value of its stock owned by certain “5-percen.

10.08.2026

Accendra Health Reports Second Quarter 2026 Financial Results

RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the Company) today reported financial results for the second quarter ended June 30, 2026. Unless otherwise noted, the results herein reflect the Company's continuing operations, which represent what was previously the Patient Direct segment and certain functional operations. “Throughout the second quarter, we moved farther along toward the complete separation from Owens & Minor while also putting a large commercial payor exi.

10.08.2026

Accendra Health's Ed Pesicka Announces Intent to Retire; Board of Directors Has Begun Successor Search

RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the Company) today announced that President and Chief Executive Officer Edward A. Pesicka has informed the Board of Directors of his plan to retire by the end of 2026, after more than seven years with the Company. Mr. Pesicka will also retire from the Company's Board of Directors before the end of the year. The Board of Directors maintains a long-standing, robust succession planning process established to address officer success.

05.08.2026

Accendra Health Q2 Preview: Low Expectations Create Opportunity

Accendra Health remains a speculative buy despite recent share declines and sector-driven volatility. ACH's limited exposure to capitated contracts and prudent exit from risky agreements mitigate margin risk seen in peers like AHCO. Balance sheet restructuring has reduced gross borrowings by at least $350 million, extending maturities and enabling future deleveraging.

Videos

No Data

There is no data to display

Upgrades / Downgrades

Ticker	Brokerage Firm	Ratings Change	Price Target	Date
ACH	Citigroup	Neutral	undefined >> $2	August 11th 2026
ACH	Robert W. Baird	Neutral	undefined >> $2	August 11th 2026

Press releases

10.08.2026

Accendra Health Announces Adoption of Tax Asset Preservation Plan To Protect Long Term Shareholder Value

10.08.2026

Accendra Health Reports Second Quarter 2026 Financial Results

10.08.2026

Accendra Health, Inc. (ACH)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Accendra Health, Inc. (ACH)

Accendra Health, Inc. (ACH) Q2 2026 Earnings Call Transcript

Accendra Health Announces Adoption of Tax Asset Preservation Plan To Protect Long Term Shareholder Value

Accendra Health Reports Second Quarter 2026 Financial Results

Accendra Health's Ed Pesicka Announces Intent to Retire; Board of Directors Has Begun Successor Search

Accendra Health Q2 Preview: Low Expectations Create Opportunity

Videos

No Data

Upgrades / Downgrades

Press releases

Accendra Health Announces Adoption of Tax Asset Preservation Plan To Protect Long Term Shareholder Value

Accendra Health Reports Second Quarter 2026 Financial Results

Accendra Health's Ed Pesicka Announces Intent to Retire; Board of Directors Has Begun Successor Search

Accendra Health, Inc. (ACH) Q2 2026 Earnings Call Transcript

Accendra Health Announces Adoption of Tax Asset Preservation Plan To Protect Long Term Shareholder Value

Accendra Health Reports Second Quarter 2026 Financial Results

Accendra Health's Ed Pesicka Announces Intent to Retire; Board of Directors Has Begun Successor Search

Accendra Health Q2 Preview: Low Expectations Create Opportunity

Videos

No Data

Upgrades / Downgrades

Press releases

Accendra Health Announces Adoption of Tax Asset Preservation Plan To Protect Long Term Shareholder Value

Accendra Health Reports Second Quarter 2026 Financial Results

Accendra Health's Ed Pesicka Announces Intent to Retire; Board of Directors Has Begun Successor Search

Search stocks

Accendra Health, Inc. (ACH)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Accendra Health, Inc. (ACH)

Accendra Health, Inc. (ACH) Q2 2026 Earnings Call Transcript

Accendra Health Announces Adoption of Tax Asset Preservation Plan To Protect Long Term Shareholder Value

Accendra Health Reports Second Quarter 2026 Financial Results

Accendra Health's Ed Pesicka Announces Intent to Retire; Board of Directors Has Begun Successor Search

Accendra Health Q2 Preview: Low Expectations Create Opportunity

Videos

No Data

Upgrades / Downgrades

Press releases

Accendra Health Announces Adoption of Tax Asset Preservation Plan To Protect Long Term Shareholder Value

Accendra Health Reports Second Quarter 2026 Financial Results

Accendra Health's Ed Pesicka Announces Intent to Retire; Board of Directors Has Begun Successor Search

Accendra Health, Inc. (ACH) Q2 2026 Earnings Call Transcript

Accendra Health Announces Adoption of Tax Asset Preservation Plan To Protect Long Term Shareholder Value

Accendra Health Reports Second Quarter 2026 Financial Results

Accendra Health's Ed Pesicka Announces Intent to Retire; Board of Directors Has Begun Successor Search

Accendra Health Q2 Preview: Low Expectations Create Opportunity

Videos

No Data

Upgrades / Downgrades

Press releases

Accendra Health Announces Adoption of Tax Asset Preservation Plan To Protect Long Term Shareholder Value

Accendra Health Reports Second Quarter 2026 Financial Results

Accendra Health's Ed Pesicka Announces Intent to Retire; Board of Directors Has Begun Successor Search